Peter MacCallum Cancer Centre shared a post on LinkedIn:
“New research at Peter Mac will investigate which patients are most likely to respond immunotherapy for head and neck cutaneous squamous cell carcinoma (CSCC).
Funded by a Passe and Williams Foundation mid-career fellowship, clinician-researcher Associate Professor Annette Lim will “conduct comprehensive molecular profiling of immunotherapy-responsive and resistant CSCC to identify molecular features or biomarkers”.
Other articles featuring CSCC on OncoDaily.